National Center for Nuclear Research
UkraineAll drugs from this manufacturer
-
This drug is used exclusively for diagnostic purposes. It is used for renal scintigraphy analysis (assessment of kidney function and urine excretion), measurement of glomerular filtration rate, as well as for cerebral angiography and brain scanning.
Dosage form: kit for preparation of radiopharmaceutical preparation
Active substance Dosage sodium diethylenetriaminepentaacetate 13.25 mg ATC: V09CA01
-
This drug is used exclusively for the diagnosis of skeletal bone diseases by performing scintigraphy.
Dosage form: kit for preparation of radiopharmaceutical preparation
Active substance Dosage methylene diphosphonic acid 5 mg ATC: V09BA02
-
This drug is used exclusively for diagnostic purposes. It is used for myocardial scintigraphy (detection of coronary artery diseases), assessment of ventricular function, scintimammography (when breast cancer is suspected), and localization of hyperfunctioning parathyroid tissue.
Dosage form: kit for preparation of radiopharmaceutical preparation
Active substance Dosage tetrakis(2-methoxy-2-methylpropyl-1-isocyanide) copper(1+) tetrafluoroborate 1 mg ATC: V09GA01
-
The drug is used exclusively for diagnostic purposes. It is used for scintigraphy of the thyroid and salivary glands, lacrimal ducts, as well as for the localization of ectopic gastric mucosa (Meckel's diverticulum).
Dosage form: radiopharmaceutical generator
Active substance Dosage sodium molybdenum-99 9.1-200 GBq sodium pertechnetate-99mtc 8.0-175 GBq ATC: V09FX01
-
The drug is used for the diagnosis and treatment of thyroid diseases. It is applied to assess its function, size, and the presence of nodules, as well as for the treatment of hyperthyroidism, goiter, metastases, and residual thyroid tissue after surgery.
Dosage form: solution for injection
Active substance Dosage sodium iodide i 131 37 740 MBq ml -
The drug is used to treat non-toxic multinodular goiter, hyperthyroidism (Graves' disease – Basedow's disease), single nodules, and toxic multinodular goiter. It is also used to remove thyroid remnants after surgery for differentiated tumors and to treat iodine-accumulating metastases.
Dosage form: capsules, hard
Active substance Dosage sodium iodide i 131 1000 MBq ATC: V10XA01
-
The drug is used to treat non-toxic nodular goiter, hyperthyroidism (Graves' disease – Basedow's disease), single nodules, and toxic multinodular goiter. It is also used to remove thyroid remnants after surgery for differentiated tumors and to treat iodine-accumulating metastases.
Dosage form: capsules, hard
Active substance Dosage sodium iodide i 131 2000 MBq ATC: V10XA01
-
The drug is used to treat non-toxic nodular goiter, hyperthyroidism (Graves' disease – Basedow's disease), single nodules, and toxic multinodular goiter. It is also used to remove thyroid remnants after surgery for differentiated tumors and to treat iodine-accumulating metastases.
Dosage form: capsules, hard
Active substance Dosage sodium iodide i 131 4000 MBq ATC: V10XA01
-
The drug is used to treat non-toxic multinodular goiter, hyperthyroidism (Graves' disease – Basedow's disease), single nodules, and toxic multinodular goiter. It is also used to remove thyroid remnants after surgery for differentiated tumors and to treat iodine-accumulating metastases.
Dosage form: capsules, hard
Active substance Dosage sodium iodide i 131 5500 MBq ATC: V10XA01